Loading institutional data...
Loading institutional data...
Held by 839 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 9%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $529M covers the $8M due within a year 65.3× over. Scheduled principal only (excludes interest & revolver draws). As of 2014-09-30 (10-Q).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 496 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMZN | $2.93T | — | — | — | — | — | — | 20.5% | 16.2% | — | 5,764 |
| TSLA | $1.21T | 297.7× | 127.6× | 12.7× | -2.9% | 18.0% | 4.0% | 4.6% | 4.2% | 0.9× | 4,029 |
| PDD | $517.8B | 38.5× | 37.5× | 8.4× | -84.3% | 56.3% | 22.7% | 23.7% | 23.7% | — | 548 |
| HD | $351.7B | 24.8× | 16.4× | 2.1× | 3.2% | 33.3% | 8.6% | 111% | 22.8% | 2.0× | 3,970 |
| TOYOF | $242.7B | — | — | — | — | — | — | — | — | — | 4 |
| TJX | $177.0B | 32.8× | — | 2.9× | 7.1% | 31.0% | 9.1% | 53.9% | 45.6% | — | 2,608 |
| LOW | $123.4B | 18.6× | 13.1× | 1.4× | 3.1% | 33.5% | 7.7% | -67.1% | 22.3% | 3.2× | 2,591 |
| SBUX | $120.5B | 65.0× | 28.7× | 3.2× | 2.8% | — | 5.0% | -22.9% | 28.7% | 3.1× | 2,252 |
| MELI | $97.5B | 48.8× | — | 3.4× | 39.1% | 44.5% | 6.9% | 29.6% | 12.5% | — | 1,380 |
| MAR | $96.1B | 38.0× | 22.3× | 3.7× | 4.3% | — | 9.9% | -69.0% | -69.4% | 0.0× | 1,559 |
| LKNCY | $94.1B | 183.4× | 99.1× | 13.4× | -79.6% | — | 7.3% | 23.0% | 23.0% | 0.0× | 9 |
| ABNB | $93.5B | — | 33.9× | 7.6× | 10.3% | 83.0% | 20.5% | 30.6% | 30.6% | 0.0× | 1,246 |
| RCL | $88.7B | 21.0× | — | 5.0× | 8.8% | 49.4% | 23.8% | 42.5% | 12.3% | — | 1,114 |
| ROST | $81.6B | 38.3× | 24.3× | 3.6× | 7.7% | 27.7% | 9.4% | 34.7% | 29.8% | 0.3× | 1,276 |
| GM | $80.6B | 27.3× | 4.0× | 0.4× | -1.3% | — | 1.5% | 4.5% | 4.5% | — | 1,447 |
| ORLY | $78.7B | 31.5× | 21.3× | 4.4× | 6.4% | 51.6% | 14.3% | -333% | 48.3% | 1.5× | 1,569 |
| HLT | $74.8B | 53.0× | 25.7× | 6.2× | 7.7% | — | 12.1% | -27.0% | -27.0% | — | 1,126 |
| RACE | $71.5B | — | — | — | — | — | — | — | — | — | 690 |
| SE | $70.4B | 45.6× | 28.1× | 3.1× | 36.4% | 44.7% | 6.9% | 12.6% | 12.6% | — | 718 |
| NKE | $63.0B | 20.2× | — | 1.4× | 0.2% | 42.9% | 6.7% | 20.9% | 14.9% | — | 1,848 |
| AZO | $51.4B | 21.1× | 14.2× | 2.7× | 2.4% | 52.6% | 13.2% | -73.2% | 46.4% | 2.1× | 1,245 |
| EBAY | $49.9B | 25.6× | 18.1× | 4.5× | 7.9% | 71.5% | 18.3% | 45.3% | 38.8% | 0.3× | 1,182 |
| VIK | $48.3B | — | — | — | — | — | — | — | — | — | 479 |
| CMG | $46.1B | 30.3× | 19.9× | 3.9× | 5.4% | — | 12.9% | 54.3% | 54.3% | 0.0× | 1,203 |
| DHI | $44.6B | 13.1× | — | 1.3× | -6.9% | 23.7% | 10.5% | 14.8% | 14.8% | — | 1,092 |
| PKG | $22.9B | 29.8× | 14.9× | 2.5× | 7.2% | 21.0% | 8.6% | 16.8% | 9.0% | 2.3× | 839 |
Peers = companies sharing PKG's sector (Consumer Cyclical) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.99B 100.0% | $8.38B 100.0% | $7.80B 100.0% | $8.48B 100.0% | $7.73B 100.0% | $6.66B 100.0% | $6.96B 100.0% | $7.01B 100.0% | $6.44B 100.0% | $5.78B 100.0% |
| Cost of Revenue | $7.10B 79.0% | $6.60B 78.7% | $6.10B 78.2% | $6.39B 75.3% | $5.86B 75.8% | $5.29B 79.4% | $5.32B 76.4% | $5.37B 76.5% | $4.97B 77.2% | $4.50B 77.9% |
| Cost of Products | — | — | — | — | — | — | — | — | $4.97B 77.2% | $4.50B 77.9% |
| Gross Profit | $1.89B 21.0% | $1.78B 21.3% | $1.70B 21.8% | $2.09B 24.7% | $1.87B 24.2% | $1.37B 20.6% | $1.64B 23.6% | $1.65B 23.5% | $1.47B 22.8% | $1.28B 22.1% |
| Research & Development | — | — | — | — | $14.5M 0.2% | $15.5M 0.2% | $16.0M 0.2% | $14.4M 0.2% | $12.8M 0.2% | $13.3M 0.2% |
| Selling, General & Admin | $634.2M 7.1% | $610.3M 7.3% | $580.9M 7.4% | $608.6M 7.2% | $576.8M 7.5% | $539.6M 8.1% | $557.6M 8.0% | $536.4M 7.6% | $519.9M 8.1% | $468.5M 8.1% |
| Operating Income | $1.11B 12.3% | $1.10B 13.1% | $1.08B 13.8% | $1.42B 16.8% | $1.24B 16.1% | $723.9M 10.9% | $1.05B 15.1% | $1.07B 15.2% | $932.5M 14.5% | $783.3M 13.6% |
| Interest & Investment Income | $26.7M 0.3% | $23.2M 0.3% | $1.5M 0.0% | — | — | — | — | — | — | — |
| Pretax Income | $1.03B 11.4% | $1.06B 12.7% | $1.01B 13.0% | $1.36B 16.1% | $1.11B 14.3% | $632.7M 9.5% | $917.0M 13.2% | $970.5M 13.8% | $828.6M 12.9% | $688.5M 11.9% |
| Income Tax Expense | $253.7M 2.8% | $259.3M 3.1% | $248.9M 3.2% | $335.0M 4.0% | $267.6M 3.5% | $171.7M 2.6% | $220.6M 3.2% | $232.5M 3.3% | $160.0M 2.5% | $238.9M 4.1% |
| Net Income | $774.1M 8.6% | $805.1M 9.6% | $765.2M 9.8% | $1.03B 12.1% | $841.1M 10.9% | $461.0M 6.9% | $696.4M 10.0% | $738.0M 10.5% | $668.6M 10.4% | $449.6M 7.8% |
| Per Share | ||||||||||
| EPS (Basic) | $8.61 | $8.97 | $8.52 | $11.08 | $8.87 | $4.86 | $7.36 | $7.82 | $7.09 | $4.76 |
| EPS (Diluted) | $8.58 | $8.93 | $8.48 | $11.03 | $8.83 | $4.84 | $7.34 | $7.80 | $7.07 | $4.75 |
| Weighted Avg Shares (Basic) | 89.3M | 89.1M | 89.1M | 92.3M | 94.1M | 94.1M | 93.8M | 93.7M | 93.5M | 93.5M |
| Weighted Avg Shares (Diluted) | 89.6M | 89.5M | 89.5M | 92.7M | 94.5M | 94.4M | 94.1M | 93.9M | 93.7M | 93.7M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $256.01 today, the market must believe free cash flow compounds 16.3%/yr for a decade (off $699M normalized FCF).
The market's 16.3% is more optimistic than its 9-yr track record.
2-stage DCF · 0.09B shares · net debt $3.4B
mean 7.5% · volatility σ 29% · implied rate exceeded in 5/9 yrs
Central path = implied 16.3%/yr growth; shaded band = ±1σ (29%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 62% of free cash flow, leaving room to grow it and fund buybacks. Last year: $450M dividends + $153M buybacks = $603M returned on $729M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
EOD close · as of 2026-08-05
No standout strengths flagged.
No material risks flagged.
Where each multiple sits in its own 14-yr range · 100th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 76.5 | 76.4 | 79.4 | 75.8 | 75.3 | 78.2 | 78.7 | 79.0 |
| Gross Profit | 23.5 | 23.6 | 20.6 | 24.2 | 24.7 | 21.8 | 21.3 | 21.0 |
| R&D | 0.2 | 0.2 | 0.2 | 0.2 | — | — | — | — |
| SG&A | 7.6 | 8.0 | 8.1 | 7.5 | 7.2 | 7.4 | 7.3 | 7.1 |
| Operating Income | 15.2 | 15.1 | 10.9 | 16.1 | 16.8 | 13.8 | 13.1 | 12.3 |
| Income Tax | 3.3 | 3.2 | 2.6 | 3.5 | 4.0 | 3.2 | 3.1 | 2.8 |
| Net Income | 10.5 | 10.0 | 6.9 | 10.9 | 12.1 | 9.8 | 9.6 | 8.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on PKG: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.